Management of an Integrated Project (Sens-it-iv) to Develop In Vitro Tests to 
Assess Sensitisation

Rovida, Costanza; Basketter, David; Casati, Silvia; de Silva, Odile; Hermans, Helma; Kimber, Ian; Manou, Irene; Weltzien, Hans Ulrich; Roggen, Erwin

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Management of an Integrated Project (Sens-it-iv) to Develop In Vitro Tests to Assess Sensitisation

MPS-Authors

/persons/resource/persons191380

Weltzien, Hans Ulrich
Emeritus Group: Cellular Immunology, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Rovida, C., Basketter, D., Casati, S., de Silva, O., Hermans, H., Kimber, I., et al. (2007). Management of an Integrated Project (Sens-it-iv) to Develop In Vitro Tests to Assess Sensitisation. Alternative Laboratory Animals, 35, 317-322.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002B-91E1-5

Abstract

Sens-it-iv is an integrated project, funded by European Commission Framework Programme 6, the overall objective of which is to develop in vitro tests and test strategies to be used by the chemical, cosmetic and pharmaceutical industries to assess the risk for potential contact and respiratory sensitisers. Such tests, once formally validated and accepted, will permit the evaluation of the sensitising potential of existing and new chemical entities and the products of the European industries for classification and labelling, as required by the new EU REACH legislation on chemicals, or for the purpose of risk assessment as required by the 7th Amendment to the EU Cosmetics Directive. Sens-it-iv involves 28 partners, representing industries, universities and regulatory bodies, including various institutes in the EU Member States and different competencies, all with the common aim of achieving a final deliverable - increasing the safety of consumer products, whilst reducing animal experimentation. This paper provides an overview of the structure of the project and a detailed description of the organisation of its management.